GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma
Gargett, Tessa, Ebert, Lisa M, Truong, Nga T H, Kollis, Paris M, Sedivakova, Kristyna, Yu, Wenbo, Yeo, Erica C F, Wittwer, Nicole L, Gliddon, Briony L, Tea, Melinda N, Ormsby, Rebecca, Poonnoose, Santosh, Nowicki, Jake, Vittorio, Orazio, Ziegler, David S, Pitson, Stuart M, Brown, Michael P
Published in Journal for immunotherapy of cancer (01.09.2022)
Published in Journal for immunotherapy of cancer (01.09.2022)
Get full text
Journal Article
Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers
Gargett, Tessa, Truong, Nga T H, Gardam, Bryan, Yu, Wenbo, Ebert, Lisa M, Johnson, Amy, Yeo, Erica C F, Wittwer, Nicole L, Tapia Rico, Gonzalo, Logan, Jesikah, Sivaloganathan, Purany, Collis, Maria, Ruszkiewicz, Andrew, Brown, Michael P
Published in Journal for immunotherapy of cancer (15.05.2024)
Published in Journal for immunotherapy of cancer (15.05.2024)
Get full text
Journal Article
Endogenous bystander killing mechanisms enhance the activity of novel FAP-specific CAR-T cells against glioblastoma
Yu, Wenbo, Truong, Nga Th, Polara, Ruhi, Gargett, Tessa, Tea, Melinda N, Pitson, Stuart M, Cockshell, Michaelia P, Bonder, Claudine S, Ebert, Lisa M, Brown, Michael P
Published in Clinical & translational immunology (01.01.2024)
Published in Clinical & translational immunology (01.01.2024)
Get full text
Journal Article